InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-50.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by VAN NOSTRAND ROBERT L, Director. Insider active across 4 companies, notably Intra-Cellular Therapies, Inc.. In total, 34 filings have been logged. History available since 30 June 2021. The latest transaction was disclosed on 2 April 2025 (Disposition). Regulator: SEC (Form 4). The full history is free.
Declarations34 total
11,340 shares@ US$132.0055.3% of flowCommon StockSEC:0000950170-25-049636:0
12,500 shares0Common StockSEC:0001104659-25-003497:0
83 shares@ US$68.490.2% of flowCommon StockSEC:0000950170-24-080987:0
1,567 sharesCommon StockSEC:0000950170-24-077472:0
20,000 shares@ US$16.8612.6% of flowCommon StockSEC:0000950170-24-076380:0
79 shares@ US$69.200.2% of flowCommon StockSEC:0000950170-24-040166:0
11,924 shares0Common StockSEC:0001628280-24-013923:0
20,000 shares@ US$18.5613.8% of flowCommon StockSEC:0000950170-24-022485:0
6,000 shares0Common StockSEC:0001104659-24-006381:0
18,879 shares0Common StockSEC:0001628280-24-000210:0
76 shares@ US$71.620.2% of flowCommon StockSEC:0000950170-24-001303:0
105 shares@ US$52.090.2% of flowCommon StockSEC:0001209191-23-051143:0
13,868 shares0Common StockSEC:0001121702-23-000056:0
85 shares@ US$63.320.2% of flowCommon StockSEC:0001209191-23-041084:0
2,040 shares0Common StockSEC:0001628280-23-024201:0
10,000 shares@ US$13.054.8% of flowCommon StockSEC:0001209191-23-024899:0
1,642 shares0Common StockSEC:0001628280-23-010704:0
95 shares@ US$54.150.2% of flowCommon StockSEC:0001209191-23-022799:0
2,500 shares0Common StockSEC:0001104659-23-010623:0
97 shares@ US$52.920.2% of flowCommon StockSEC:0001209191-23-000197:0
110 shares@ US$46.530.2% of flowCommon StockSEC:0001209191-22-052716:0
20,000 shares@ US$12.459.7% of flowCommon StockSEC:0001209191-22-045685:0
108 shares@ US$57.080.2% of flowCommon StockSEC:0001209191-22-040571:0
126 shares@ US$61.1915.0% of flowCommon StockSEC:0001209191-22-022323:0
1,900 shares0Common StockSEC:0001104659-22-010397:0
25 of 34 declarations
About VAN NOSTRAND ROBERT L
Robert L. Van Nostrand is a Board Member of Intra-Cellular Therapies, Inc. and SELLAS Life Sciences Group, Inc. As a board member, he participates in the governance of the companies and strategic decision-making. Robert leverages his experience to help guide the direction of the companies and ensure compliance with regulatory standards.
